HomeSearchGlobal LocationsContact UsGenzyme Websites
About GenzymeOur ResearchOur ProductsOur Commitment
Genzyme

Corporate Info
Investors
News
Investor Events
Financial Reports
Guidance and Reconciliation
Research Pipeline
Analyst Coverage
Frequently Asked Questions
News
Partnering and Licensing
Genzyme Events
Careers
Global Locations

News

News Releases

News Subscription


Genzyme’s Most Recent News

inv_genz_news Genzyme General News
May 7, 2008 Preliminary Results from Phase 2 Genzyme Study
April 25, 2008 FDA Provides Clarity to Isis Regarding the Development Path for Mipomersen
April 23, 2008 Genzyme Reports Strong First-Quarter Growth
April 22, 2008 Genzyme to Build New R&D Center in Beijing
April 21, 2008 Genzyme Provides Update on Myozyme® Manufacturing
April 14, 2008 Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
March 19, 2008 Genzyme Withdraws Bioenvision’s European Filing of Evoltra® in Elderly AML Patients
March 10, 2008 Genzyme Announces Presentation of New Positive Data on Carticel®
March 6, 2008 Genzyme Launches Renvela® in the U.S. for Dialysis Patients
February 13, 2008 Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year

Genzyme News—One Year Archive >
Genzyme Financial News >




Search News Releases

 

Financial News

Latest Earnings Report:

First Quarter 2008

Annual Report:

2007 Annual Report (HTML)
2006 Annual Report (HTML)


CONTACT INFORMATION:
Genzyme Investor Relations
500 Kendall Street
Cambridge, MA 02142
T: 617 252 7500
F: 617 374 7368


Patrick Flanigan – 617 768 6563


Investor Information Line

U.S. T: 800 905 4369
Outside the U.S. T: 678 999 4572

Shareholder Contact

For questions about your shares, replacement of a lost stock certificate or a change of address call our transfer agent.

American Stock Transfer

59 Maiden Lane
New York, NY 10038
T: 212 936 5100
or
Genzyme Shareholder Services
T: 617 768 6686

Terms and Conditions of Use | Privacy Policy | © 2002-2008 Genzyme Corporation. All rights reserved.